Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Ethicon to market Polartechnics's cervical screening device

Executive Summary

J7J's Ethicon will market and distribute TruScan, the noninvasive cervical cancer screening system developed by Polartechnics Ltd., worldwide, except for Australasia, Taiwan, Korea, Philippines, Singapore, Malaysia and Indochina, territories to which Polartechnics retains rights. Ethicon will market and distribute TruScan, the non-invasive cervical cancer screening system developed by Polartechnics Ltd., worldwide, except for Australasia, Taiwan, Korea, Philippines, Singapore, Malaysia and Indochina, territories to which Polartechnics retains rights.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register